Glimepiride Drug Profile

What is Glimepiride?

Glimepiride is an oral antidiabetic medication belonging to the sulfonylurea class of drugs. It is primarily prescribed to help control blood sugar levels in adults with type 2 diabetes mellitus. Glimepiride works by stimulating the pancreas to produce more insulin, making it effective for patients whose bodies still produce some natural insulin.

Uses

Type 2 diabetes management: The primary indication for glimepiride is as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Combination therapy: Often used alongside other antidiabetic medications such as metformin or insulin when single-drug therapy is insufficient to achieve target blood glucose levels.

Monotherapy: May be prescribed as a single medication for patients who cannot tolerate metformin or when metformin is contraindicated.

Submit Your Paper

Secondary diabetes treatment: Sometimes used in patients who have progressed from diet and lifestyle modifications alone to requiring pharmaceutical intervention.

How it works

Glimepiride stimulates insulin release from the beta cells in the pancreas by binding to specific receptors on these cells and blocking potassium channels. This action causes the cells to depolarize, leading to calcium influx and subsequent insulin secretion. The medication only works effectively when the pancreas retains some ability to produce insulin, which is why it is not suitable for type 1 diabetes.

Side effects

Common side effects:

• Hypoglycemia (low blood sugar)
• Weight gain
• Nausea
• Dizziness
• Headache
• Upper respiratory tract infections
• Diarrhea
• Allergic skin reactions

Serious side effects requiring immediate medical attention:

• Severe hypoglycemia with confusion, seizures, or loss of consciousness
• Severe allergic reactions including skin rash, difficulty breathing, or swelling
• Liver problems indicated by yellowing of skin or eyes
• Blood disorders such as unusual bleeding or bruising
• Hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency

Warnings and precautions

Contraindications: Glimepiride should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or known hypersensitivity to sulfonylureas or sulfonamides.

Kidney and liver function: Dosage adjustments may be necessary in patients with impaired kidney or liver function, as the medication is metabolized by the liver and excreted by the kidneys.

Pregnancy and breastfeeding: Glimepiride is not recommended during pregnancy due to potential risks to the developing fetus. Women planning pregnancy should discuss alternative diabetes management strategies with their healthcare provider.

Elderly patients: Older adults may be more sensitive to the hypoglycemic effects and may require lower initial doses and more frequent blood glucose monitoring.

Stress conditions: During periods of stress, fever, infection, or surgery, temporary insulin therapy may be needed as glimepiride may not provide adequate glucose control.

Interactions

Alcohol: Can enhance hypoglycemic effects and may cause unpredictable blood sugar changes.

Beta-blockers: May mask symptoms of hypoglycemia and can affect blood sugar control.

Fluconazole and other azole antifungals: Can increase glimepiride levels in the blood, potentially leading to hypoglycemia.

Rifampin: May decrease glimepiride effectiveness by increasing its metabolism.

Warfarin: Glimepiride may enhance anticoagulant effects, requiring more frequent INR monitoring.

NSAIDs: May increase risk of hypoglycemia when used concurrently.

ACE inhibitors: Can enhance blood sugar-lowering effects.

Corticosteroids: May counteract glimepiride’s effects and raise blood sugar levels.

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults is 1-2 mg once daily, taken with breakfast or the first main meal of the day. The dose may be gradually increased based on blood glucose response, usually in increments of 1-2 mg every 1-2 weeks. The maximum recommended daily dose is 8 mg. Patients transferring from other antidiabetic medications may require different starting doses. Dosage should always be individualized based on patient response, kidney function, and other clinical factors. Healthcare providers should determine the appropriate dose for each patient based on their specific medical condition and treatment goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).